794 results on '"Werner-Wasik, Maria"'
Search Results
102. Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial
103. A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
104. Initial Clinical Experience of MR-Guided Radiotherapy for Non-Small Cell Lung Cancer
105. Stereotactic body radiation therapy (SBRT) for patients with stage I non-small cell lung cancer is applicable to more tumors than sublobar resection
106. Machine Learning Analysis of Local Recurrence of Meningioma Treated with Stereotactic Radiotherapy
107. Phase Ib Clinical Trial of IGV-001 for Patients with Newly Diagnosed Glioblastoma
108. Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: a long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis
109. Stereotactic image-guided lung radiotherapy (SBRT) for clinical early-stage NSCLC: a long-term report from a multi-institutional database of patients treated with or without a pathologic diagnosis
110. Definitive radiotherapy for meningeal brainstem melanocytoma: a case report
111. CTNI-21. SCALP SPARING RADIATION WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATMENT FIELDS (SPARE) FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
112. A Collaborative Analysis of Stereotactic Lung Radiotherapy Outcomes for Early-Stage Non–Small-Cell Lung Cancer Using Daily Online Cone-Beam Computed Tomography Image-Guided Radiotherapy
113. Improving Prognosis of Glioblastoma in the 21St Century: Who Has Benefited Most?
114. Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?
115. A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
116. Impact of Sarcopenia on Survival in Patients With Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
117. Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC.
118. Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.
119. Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic
120. Abstract B71: Phase 1b/2 prospective randomized trial of four autologous cell vaccine dose cohorts for initial treatment of glioblastoma
121. ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402
122. ACTR-49. INITIAL EXPERIENCE WITH SCALP PRESERVATION AND RADIATION PLUS CONCURRENT ALTERNATING ELECTRIC TUMOR-TREATING FIELDS (SPARE) FOR GLIOBLASTOMA PATIENTS
123. Atypical and malignant meningiomas: an outcome report of seventeen cases
124. MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors
125. Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: An analysis of patients treated at one institution
126. Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non–small-cell lung cancer treated in stereotactic body frame
127. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas
128. Lymphadenopathy
129. Phase II Trial of Radiosurgery for One to Three Newly Diagnosed Brain Metastases From Renal Cell Carcinoma, Melanoma, and Sarcoma: An Eastern Cooperative Oncology Group Study (E 6397)
130. What Should the Optimal Timing Be for Amifostine Administration Relative to Radiation and Chemotherapy?
131. Randomized Trial of Amifostine in Locally Advanced Non–Small-Cell Lung Cancer Patients Receiving Chemotherapy and Hyperfractionated Radiation: Radiation Therapy Oncology Group Trial 98-01
132. Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer
133. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol
134. Fractionated Stereotactic Radiotherapy For the Treatment of Large Arteriovenous Malformations with or without Previous Partial Embolization
135. On “Comparison of Methods for Response Analysis of Central Nervous System Neoplasms”
136. Fractionated Stereotactic Radiotherapy for the Treatment of Optic Nerve Sheath Meningiomas: Preliminary Observations of 33 Optic Nerves in 30 Patients with Historical Comparison to Observation with or without Prior Surgery
137. Preliminary Report on Reduction of Esophagitis by Amifostine in Patients with Non-Small-Cell Lung Cancer Treated with Chemoradiotherapy
138. Evaluating changes in radiation treatment volumes from post-operative to same-day planning MRI in High-grade gliomas
139. Evaluating Tumor Response in the Brain: Surface or Volume?
140. Abstract CT038: Results of a Phase Ib trial of an autologous cell vaccine for newly diagnosed glioblastoma
141. Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) +/- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).
142. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment
143. Long-Term Outcomes for Nonacoustic Schwannomas Treated with Stereotactic Radiation Therapy
144. Long-Term Visual Outcomes and Prognostic Indicators following Fractionated Stereotactic Radiotherapy for Optic Nerve Sheath Meningiomas
145. Multiple courses of stereotactic re-irradiation in recurrent oligodendroglioma: a case report
146. Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma
147. RTHP-10. LESS IS MORE OR BIGGER IS BETTER? RADIATION TREATMENT VOLUME FOR GLIOBLASTOMA PATIENTS DOES NOT IMPACT SURVIVAL
148. ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS
149. Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
150. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation Therapy Oncology Group Study 83-02
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.